Journal of Clinical Oncology, Vol 16, 165-172, Copyright © 1998 by American Society of Clinical Oncology

ARTICLES

Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation

C Hesdorffer, J Ayello, M Ward, A Kaubisch, L Vahdat, C Balmaceda, T Garrett, M Fetell, R Reiss, A Bank and K Antman
Department of Medicine, College of Physicians and Surgeons of Columbia University, New York, NY, USA. csh1@columbia.edu

PURPOSE: Normal bone marrow cells have little or no expression of the MDR p-glycoprotein product and, therefore, are particularly susceptible to killing by MDR-sensitive drugs, such as vinca alkaloids, anthracyclines, podophyllins, and paclitaxel and its congeners. Here we report the results of a phase I clinical trial that tested the safety and efficacy of transfer of the human multiple drug resistance (MDR1, MDR) gene into hematopoietic stem cells and progenitors in bone marrow as a means of providing resistance of these cells to the toxic effects of cancer chemotherapy. PATIENTS AND METHODS: Up to one third of the harvested cells of patients who were undergoing autologous bone marrow transplantation as part of a high-dose chemotherapy treatment for advanced cancer were transduced with an MDR cDNA-containing retrovirus; these transduced cells were reinfused together with unmanipulated cells after chemotherapy. RESULTS: High-level MDR transduction of erythroid burst-forming unit (BFU-E) and colony-forming unit-granulocyte macrophage (CFU-GM) derived from transduced CD34+ cells was shown posttransduction and prereinfusion. However, only two of the five patients showed evidence of MDR transduction of their marrow at a low level at 10 weeks and 3 weeks, respectively, posttransplantation. The cytokine-stimulated transduced cells may be out-competed in repopulation by unmanipulated normal cells that are reinfused concomitantly. The MDR retroviral supernatant that was used was shown to be free of replication-competent retrovirus (RCR) before use, and all tests of patients' samples posttransplantation were negative for RCR. In addition, no adverse events with respect to marrow engraftment or other problems related to marrow transplantation were encountered. CONCLUSION: These results indicate the feasibility and safety of bone marrow gene therapy with a potentially therapeutic gene, the MDR gene.

This article has been cited by other articles:

				C. C. Porter and J. DeGregori Interfering RNA-mediated purine analog resistance for in vitro and in vivo cell selection Blood, December 1, 2008; 112(12): 4466 - 4474. [Abstract] [Full Text] [PDF]

				F. Bozorgmehr, S. Laufs, S. E. Sellers, I. Roeder, W. J. Zeller, C. E. Dunbar, and S. Fruehauf No Evidence of Clonal Dominance in Primates up to 4 Years Following Transplantation of Multidrug Resistance 1 Retrovirally Transduced Long-Term Repopulating Cells Stem Cells, October 1, 2007; 25(10): 2610 - 2618. [Abstract] [Full Text] [PDF]

				C. R. Ball, I. H. Pilz, M. Schmidt, S. Fessler, D. A. Williams, C. von Kalle, and H. Glimm Stable differentiation and clonality of murine long-term hematopoiesis after extended reduced-intensity selection for MGMT P140K transgene expression Blood, September 15, 2007; 110(6): 1779 - 1787. [Abstract] [Full Text] [PDF]

				M. Mimeault and S. K. Batra Concise Review: Recent Advances on the Significance of Stem Cells in Tissue Regeneration and Cancer Therapies Stem Cells, November 1, 2006; 24(11): 2319 - 2345. [Abstract] [Full Text] [PDF]

				T. Neff, B. C. Beard, and H.-P. Kiem Survival of the fittest: in vivo selection and stem cell gene therapy Blood, March 1, 2006; 107(5): 1751 - 1760. [Abstract] [Full Text] [PDF]

				U. Modlich, O. S. Kustikova, M. Schmidt, C. Rudolph, J. Meyer, Z. Li, K. Kamino, N. von Neuhoff, B. Schlegelberger, K. Kuehlcke, et al. Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesis Blood, June 1, 2005; 105(11): 4235 - 4246. [Abstract] [Full Text] [PDF]

				D. A. Persons, E. R. Allay, N. Sawai, P. W. Hargrove, T. P. Brent, H. Hanawa, A. W. Nienhuis, and B. P. Sorrentino Successful treatment of murine {beta}-thalassemia using in vivo selection of genetically modified, drug-resistant hematopoietic stem cells Blood, July 15, 2003; 102(2): 506 - 513. [Abstract] [Full Text] [PDF]

				C. L. Sweeney, J. L. Frandsen, C. M. Verfaillie, and R. S. McIvor Trimetrexate Inhibits Progression of the Murine 32Dp210 Model of Chronic Myeloid Leukemia in Animals Expressing Drug-resistant Dihydrofolate Reductase Cancer Res., March 15, 2003; 63(6): 1304 - 1310. [Abstract] [Full Text] [PDF]

				D. A. Persons, P. W. Hargrove, E. R. Allay, H. Hanawa, and A. W. Nienhuis The degree of phenotypic correction of murine beta -thalassemia intermedia following lentiviral-mediated transfer of a human gamma -globin gene is influenced by chromosomal position effects and vector copy number Blood, March 15, 2003; 101(6): 2175 - 2183. [Abstract] [Full Text] [PDF]

				W. Pfutzner, A. Terunuma, C. L. Tock, E. K. Snead, T. M. Kolodka, M. M. Gottesman, L. Taichman, and J. C. Vogel Topical colchicine selection of keratinocytes transduced with the multidrug resistance gene (MDR1) can sustain and enhance transgene expression in vivo PNAS, October 1, 2002; 99(20): 13096 - 13101. [Abstract] [Full Text] [PDF]

				T. Neff, P. A. Horn, V. E. Valli, A. M. Gown, S. Wardwell, B. L. Wood, C. von Kalle, M. Schmidt, L. J. Peterson, J. C. Morris, et al. Pharmacologically regulated in vivo selection in a large animal Blood, August 28, 2002; 100(6): 2026 - 2031. [Abstract] [Full Text] [PDF]

				T. Licht, M. Haskins, P. Henthorn, S. E. Kleiman, D. M. Bodine, T. Whitwam, J. M. Puck, M. M. Gottesman, and J. R. Melniczek Drug selection with paclitaxel restores expression of linked IL-2 receptor gamma -chain and multidrug resistance (MDR1) transgenes in canine bone marrow PNAS, February 20, 2002; (2002) 52712199. [Abstract] [Full Text] [PDF]

				K. D. Bunting ABC Transporters as Phenotypic Markers and Functional Regulators of Stem Cells Stem Cells, January 1, 2002; 20(1): 11 - 20. [Abstract] [Full Text] [PDF]

				S. E. Sellers, J. F. Tisdale, B. A. Agricola, M. E. Metzger, R. E. Donahue, C. E. Dunbar, and B. P. Sorrentino The effect of multidrug-resistance 1 gene versus neo transduction on ex vivo and in vivo expansion of rhesus macaque hematopoietic repopulating cells Blood, March 15, 2001; 97(6): 1888 - 1891. [Abstract] [Full Text] [PDF]

				Y. Hanazono, K. Terao, and K. Ozawa Gene Transfer into Nonhuman Primate Hematopoietic Stem Cells: Implications for Gene Therapy Stem Cells, January 1, 2001; 19(1): 12 - 23. [Abstract] [Full Text]

				B. Hennemann, I.-H. Oh, J. Y. Chuo, C. P. Kalberer, P. D. Schley, S. Rose-John, R. K. Humphries, and C. J. Eaves Efficient retrovirus-mediated gene transfer to transplantable human bone marrow cells in the absence of fibronectin Blood, October 1, 2000; 96(7): 2432 - 2439. [Abstract] [Full Text] [PDF]

				K. L. MacKenzie, N. R. Hackett, R. G. Crystal, and M. A. S. Moore Adenoviral vector-mediated gene transfer to primitive human hematopoietic progenitor cells: assessment of transduction and toxicity in long-term culture Blood, July 1, 2000; 96(1): 100 - 108. [Abstract] [Full Text] [PDF]

				B. Schiedlmeier, K. Kuhlcke, H. G. Eckert, C. Baum, W. J. Zeller, and S. Fruehauf Quantitative assessment of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cells engrafted in nonobese diabetic/severe combined immunodeficient mice Blood, February 15, 2000; 95(4): 1237 - 1248. [Abstract] [Full Text] [PDF]

				T. A. Steele Recent Developments in the Virus Therapy of Cancer Experimental Biology and Medicine, February 1, 2000; 223(2): 118 - 127. [Abstract] [Full Text]

				K. Kasono, J. L. Blackwell, J. T. Douglas, I. Dmitriev, T. V. Strong, P. Reynolds, D. A. Kropf, W. R. Carroll, G. E. Peters, R. P. Bucy, et al. Selective Gene Delivery to Head and Neck Cancer Cells via an Integrin Targeted Adenoviral Vector Clin. Cancer Res., September 1, 1999; 5(9): 2571 - 2579. [Abstract] [Full Text] [PDF]

				A. B. Deisseroth Clinical Trials Involving Multidrug Resistance Transcription Units in Retroviral Vectors Clin. Cancer Res., July 1, 1999; 5(7): 1607 - 1609. [Full Text] [PDF]

				K. H. Cowan, J. A. Moscow, H. Huang, J. A. Zujewski, J. O'Shaughnessy, B. Sorrentino, K. Hines, C. Carter, E. Schneider, G. Cusack, et al. Paclitaxel Chemotherapy after Autologous Stem-Cell Transplantation and Engraftment of Hematopoietic Cells Transduced with a Retrovirus Containing the Multidrug Resistance Complementary DNA (MDR1) in Metastatic Breast Cancer Patients Clin. Cancer Res., July 1, 1999; 5(7): 1619 - 1628. [Abstract] [Full Text] [PDF]

				J. A. Moscow, H. Huang, C. Carter, K. Hines, J. Zujewski, G. Cusack, C. Chow, D. Venzon, B. Sorrentino, Y. Chiang, et al. Engraftment of MDR1 and NeoR Gene-Transduced Hematopoietic Cells After Breast Cancer Chemotherapy Blood, July 1, 1999; 94(1): 52 - 61. [Abstract] [Full Text] [PDF]

				H. Hibino, K. Tani, K. Ikebuchi, M.-S. Wu, H. Sugiyama, Y. Nakazaki, T. Tanabe, S. Takahashi, A. Tojo, S. Suzuki, et al. The Common Marmoset as a Target Preclinical Primate Model for Cytokine and Gene Therapy Studies Blood, May 1, 1999; 93(9): 2839 - 2848. [Abstract] [Full Text] [PDF]

				J. A Smith and B. R Goldspiel Cancer gene therapy update Journal of Oncology Pharmacy Practice, March 1, 1999; 5(1): 7 - 21. [Abstract] [PDF]

				K. D. Bunting, J. Galipeau, D. Topham, E. Benaim, and B. P. Sorrentino Transduction of Murine Bone Marrow Cells With an MDR1 Vector Enables Ex Vivo Stem Cell Expansion, but These Expanded Grafts Cause a Myeloproliferative Syndrome in Transplanted Mice Blood, October 1, 1998; 92(7): 2269 - 2279. [Abstract] [Full Text] [PDF]

				T. Licht, M. Haskins, P. Henthorn, S. E. Kleiman, D. M. Bodine, T. Whitwam, J. M. Puck, M. M. Gottesman, and J. R. Melniczek Drug selection with paclitaxel restores expression of linked IL-2 receptor gamma -chain and multidrug resistance (MDR1) transgenes in canine bone marrow PNAS, March 5, 2002; 99(5): 3123 - 3128. [Abstract] [Full Text] [PDF]